Porton Pharma Solutions Ltd. (SHE:300363)
China · Delayed Price · Currency is CNY 24.48
+4.08 (20.00%)
Aug 20, 2026, 3:04 PM CST
Porton Pharma Solutions Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 793.84 | 1,131 | 1,475 | 1,967 | 2,850 | 1,217 |
Trading Asset Securities | 551.89 | 279.28 | - | - | - | - |
Cash & Short-Term Investments | 1,346 | 1,411 | 1,475 | 1,967 | 2,850 | 1,217 |
Cash Growth | -6.60% | -4.34% | -25.02% | -31.01% | 134.24% | -3.90% |
Accounts Receivable | 872.84 | 797.47 | 829.5 | 690.57 | 1,506 | 1,088 |
Other Receivables | 47.67 | 45.57 | 36.4 | 44.99 | 60.91 | 66.74 |
Receivables | 920.51 | 843.05 | 865.9 | 735.56 | 1,567 | 1,154 |
Inventory | 790.85 | 770.38 | 771.31 | 717.07 | 902.2 | 757.39 |
Other Current Assets | 253.32 | 250.37 | 129.63 | 235.13 | 142.9 | 82.2 |
Total Current Assets | 3,310 | 3,274 | 3,241 | 3,654 | 5,463 | 3,211 |
Property, Plant & Equipment | 3,767 | 3,879 | 4,100 | 4,212 | 3,381 | 2,316 |
Long-Term Investments | 382.24 | 362.8 | 347.15 | 388.03 | 372.65 | 377.13 |
Goodwill | 288.78 | 290.46 | 292.91 | 291.29 | 330.11 | 280.43 |
Other Intangible Assets | 247.03 | 251.7 | 258.75 | 275.16 | 267.1 | 130.8 |
Long-Term Deferred Tax Assets | 55.66 | 51.12 | 64.19 | 74.68 | 62.79 | 58.92 |
Long-Term Deferred Charges | 392.13 | 406.5 | 426.35 | 430.39 | 159.66 | 63.79 |
Other Long-Term Assets | 34.49 | 34.89 | 85.4 | 58.11 | 108.33 | 123.54 |
Total Assets | 8,477 | 8,551 | 8,816 | 9,384 | 10,144 | 6,562 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 833.16 | 844.7 | 899.26 | 796.14 | 1,788 | 1,111 |
Accrued Expenses | 145.28 | 237.16 | 183.56 | 196.32 | 490.75 | 210.18 |
Short-Term Debt | 10 | 10 | 66.01 | 20.03 | 303.35 | 389.66 |
Current Portion of Long-Term Debt | 535.44 | 429.14 | 329.41 | 216.01 | 69.09 | 95.27 |
Current Portion of Leases | - | 57.85 | 55.73 | 45.42 | 31.08 | 24.5 |
Current Income Taxes Payable | 39.43 | 3.72 | 10.89 | 6.17 | 55.88 | 34.83 |
Current Unearned Revenue | 148.31 | 181.4 | 100.98 | 57.5 | 73.63 | 63.68 |
Other Current Liabilities | 74.23 | 31.98 | 59.35 | 53.81 | 204.3 | 189.38 |
Total Current Liabilities | 1,786 | 1,796 | 1,705 | 1,391 | 3,016 | 2,119 |
Long-Term Debt | 428.01 | 481.28 | 908.98 | 1,070 | 312.91 | 24 |
Long-Term Leases | 514.76 | 532 | 595.99 | 621.38 | 207.33 | 207.34 |
Long-Term Unearned Revenue | 175.43 | 168.7 | 147.98 | 109.99 | 65.25 | 18.26 |
Long-Term Deferred Tax Liabilities | 89.26 | 74.82 | 46.78 | 91.04 | 70.52 | 7.79 |
Total Liabilities | 2,993 | 3,053 | 3,405 | 3,284 | 3,672 | 2,376 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 543.44 | 543.44 | 545.46 | 546.04 | 546.03 | 544.4 |
Additional Paid-In Capital | 1,943 | 1,943 | 2,041 | 2,067 | 1,958 | 1,799 |
Retained Earnings | 2,867 | 2,839 | 2,742 | 3,293 | 3,628 | 1,728 |
Treasury Stock | -29.87 | -29.87 | -129.85 | -135.27 | -133.1 | -61.83 |
Comprehensive Income & Other | 34.61 | 55.27 | -0.89 | 29.24 | 4.28 | -27.3 |
Total Common Equity | 5,358 | 5,351 | 5,198 | 5,801 | 6,003 | 3,982 |
Minority Interest | 126.05 | 147.44 | 213.2 | 299.17 | 469.17 | 204.53 |
Shareholders' Equity | 5,484 | 5,498 | 5,411 | 6,100 | 6,472 | 4,186 |
Total Liabilities & Equity | 8,477 | 8,551 | 8,816 | 9,384 | 10,144 | 6,562 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,488 | 1,510 | 1,956 | 1,973 | 923.77 | 740.77 |
Net Cash (Debt) | -142.48 | -99.74 | -481.6 | -6.61 | 1,927 | 476.1 |
Net Cash Growth | - | - | - | - | 304.68% | -53.09% |
Net Cash Per Share | -0.25 | -0.19 | -0.89 | -0.01 | 3.55 | 0.88 |
Filing Date Shares Outstanding | 557.3 | 542.18 | 542.18 | 546.04 | 546.03 | 544.4 |
Total Common Shares Outstanding | 557.3 | 542.18 | 542.18 | 546.04 | 546.03 | 544.4 |
Working Capital | 1,525 | 1,478 | 1,536 | 2,263 | 2,447 | 1,092 |
Book Value Per Share | 9.61 | 9.87 | 9.59 | 10.62 | 10.99 | 7.31 |
Tangible Book Value | 4,822 | 4,809 | 4,646 | 5,234 | 5,406 | 3,570 |
Tangible Book Value Per Share | 8.65 | 8.87 | 8.57 | 9.59 | 9.90 | 6.56 |
Buildings | - | 1,005 | 990.29 | 1,003 | 800.28 | 647.71 |
Machinery | - | 3,625 | 3,545 | 3,120 | 2,335 | 1,820 |
Construction In Progress | - | 475.05 | 437.4 | 693.46 | 1,029 | 341.58 |